Co-enzyme Q10 and Glycyrrhizic acid mitigate the renal toxicity induced by carbamazepine and erythromycin in pre-adult rats.
International Journal of Clinical Medical Research · 09.04.2026 · 4 (3) · 140-147
DOI: 10.61466/ijcmr4030002 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Medical Research, online erschienen am 01.06.2026. Verfasst von Sara Youssif Ibrahim und 3 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Carbamazepine (CBZ) is a widely used anticonvulsant and mood stabilizer with potent antiepileptic activity. However, co-administration with erythromycin (EM) may enhance CBZ toxicity, potentially inducing renal injury. Co-enzyme Q10 (CoQ10) and glycyrrhizic acid (GA) possess antioxidant and cytoprotective properties that may mitigate drug-induced nephrotoxicity.
Methods
Rats were divided into five groups: (I) negative control; (II) CBZ+EM; (III) CBZ+EM+CoQ10; (IV) CBZ+EM+GA; and (V) CBZ+EM+CoQ10+GA. CBZ (750 mg/day) was administered orally for 21 consecutive days, while EM (800 mg/day) was given during the last 5 days. CoQ10 (120 mg/day) and GA (150 mg/day) were administered for 21 days. Renal oxidative stress markers, including reduced glutathione (GSH), superoxide dismutase (SOD), and malondialdehyde (MDA), were assessed. Serum urea and creatinine levels were measured as indicators of renal function.
Results
CoQ10 and/or GA administration significantly increased GSH levels and SOD activity while significantly reducing MDA levels compared with the CBZ+EM group. Additionally, serum urea and creatinine levels were significantly decreased. The combined therapy demonstrated superior renoprotective effects compared with either agent alone.
Conclusion
Concurrent administration of CoQ10 and GA effectively attenuated CBZ- and EM-induced renal injury, likely through antioxidant mechanisms, with combined treatment providing enhanced protection. Additionally, inflammatory markers (TNF-α and Caspase-3) were significantly improved.
Zitieren
APA
Ibrahim, S. Y., Fikry, E. M., Ahmed, H. I., & Mansour, H. A. (2026). Co-enzyme Q10 and Glycyrrhizic acid mitigate the renal toxicity induced by carbamazepine and erythromycin in pre-adult rats. International Journal of Clinical Medical Research, 4(3), 140-147. https://doi.org/10.61466/ijcmr4030002
Vancouver
Ibrahim SY, Fikry EM, Ahmed HI, Mansour HA. Co-enzyme Q10 and Glycyrrhizic acid mitigate the renal toxicity induced by carbamazepine and erythromycin in pre-adult rats. International Journal of Clinical Medical Research. 2026;4(3):140-147. doi:10.61466/ijcmr4030002
BibTeX
@article{Ibrahim2026,
author = {Ibrahim, Sara Youssif and Fikry, Ebtehal Mohammad and Ahmed, Hebatalla I. and Mansour, Hanaa A.},
title = {Co-enzyme Q10 and Glycyrrhizic acid mitigate the renal toxicity induced by carbamazepine and erythromycin in pre-adult rats},
journal = {International Journal of Clinical Medical Research},
year = {2026},
volume = {4},
number = {3},
pages = {140--147},
doi = {10.61466/ijcmr4030002}
}
EUVIMED